790 likes | 802 Views
This report presents a strategic analysis of the Mexico Patient Engagement Solutions Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook.<br><br>To get a detailed report, contact us at - info@insights10.com
E N D
A sample report on Mexico Patient Engagement Solutions Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2023 – 2030F) www.insights10.com
This report presents a strategic analysis of the Mexico Patient Engagement Solutions Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Mexico Patient Engagement Solutions Market , and offers unmatched value, accuracy, and expert insights
Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Table of Content CONTENT PG. NO. 12-25 1. Patient Engagement Solutions Overview 1.1. Overview 1.2. Mexico Overview 1.3. Economic Overview: Mexico 1.4. Patient Engagement Solutions market in Mexico 1.5. Healthcare Services Market in Mexico 1.6. Healthcare Scenario in Mexico 1.7. Health Insurance Coverage: Mexico 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 26-33 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 4 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. Component 2.2.2. Therapeutic area 2.2.3. Functionality 2.2.4. Delivery mode 34-38 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. Mexico Patient Engagement Solutions Market Driver 1 3.1.2. Mexico Patient Engagement Solutions Market Driver 2 3.1.3. Mexico Patient Engagement Solutions Market Driver 3 3.2. Market Restraints 3.2.1. Mexico Patient Engagement Solutions Market Restraint 1 5 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Table of Content CONTENT PG. NO. 3.2.2. Mexico Patient Engagement Solutions Market Restraint 2 3.2.3. Mexico Patient Engagement Solutions Market Restraint 3 39-49 4. Competitive Landscape 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. Epic Systems corporation 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 6 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Table of Content CONTENT PG. NO. 4.2.2. AdvancedMD ( Global payments Inc.) 4.2.2.2. Overview 4.2.2.2. Product Applications & Services 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. Allscripts Healthcare 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 7 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Table of Content CONTENT PG. NO. 4.2.4. Athenahealth 4.2.4.2. Overview 4.2.4.2. Product Applications & Services 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. Cerner Corporation 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 8 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Table of Content CONTENT PG. NO. 4.2.6. EMMI Solutions 4.2.6.1. Overview 4.2.6.2. Product Applications & Services 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. GetWellNetwork 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 9 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Table of Content CONTENT PG. NO. 4.2.8. Lincor Solutions Limited 4.2.8.1. Overview 4.2.8.2. Product Applications & Services 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. McKesson corporation 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 10 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Table of Content CONTENT PG. NO. 4.2.10. Medecision Inc. ( Health care service corporation ) 4.2.10.2. Overview 4.2.10.2. Product Applications & Services 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 50-57 5. Reimbursement Scenario 5.1. Reimbursement Regulation 5.2. Reimbursement Process for Nutritional Supplements 58-63 6. Methodology & Scope 11 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Mexico Patient Engagement Solutions Market Analysis 1. Patient Engagement Solutions Market Overview
1.1 Statistics at a Glance: Patient Engagement Solutions in the world Prevalence of Patient Engagement Solutions Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 18.1% Is the CAGR at which patient portal market a component of patient engagement solutions is predicted to grow 3.2 Mn Medical IOT devices were installed by healthcare organizations globally in 2021 In this section you will get an understanding of the topic, which includes the prevalence of patient engagement solutions, CAGR and revenue , new technology, and other details related to the topic ▪ Software Component had the highest market share in patient engagement solutions market in 2022 $70 Bn Was mHeath apps market size in the year 2022 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ $17.3 Bn Was the Patient Engagement Solutions market size in the year 2022 13.55% Is the CAGR by which patient engagement solutions market is expected to grow till forecast of 2029 Illustrative Illustrative 13 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.1 Statistics at a Glance: Patient Engagement Solutions in the World (continued) Europe ~Revenue to reach $7.6 Bn by 2027 North America ~ Market Size of $XX Bn Asia -Fastest CAGR Mexico Market ~$XX Mn Market Africa ~Market Size of $0.6Bn Illustrative Illustrative 14 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.2 Mexico Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 129.9 Mn Is the population of Mexico, in 2022 1400 Bn Is the Gross Domestic Product (GDP) in mexico in 2022 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 29.3 Is the median age in Mexico, in 2022 $538.5 Per capita was the amount of national health expenditures in 2022 Illustrative Illustrative 15 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.3 Economic Overview: Mexico Population of Mexico, (2020-2030) GDP of Mexico, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 48.87 Female 51.13 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 16 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.4 Statistics at a Glance: Patient Engagement Solutions in Mexico Prevalence of Patient Engagement Solutions Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 3000 plus Private hospitals in Mexico use patient engagement solutions. $ 266.07 Mn Revenue from teleconsultations was generated in Mexico in 2021. In this section you will get an understanding of the topic, which includes the prevalence of patient engagement solutions in Mexico, new technology, and other details related to the topic in Mexico ▪ On premise Mode is the main preferred mode of electronic health records by hospitals in Mexico. 2.53 Mn Patients used telemedicine in 2021 in Mexico. In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ $ 82 Bn Is the total healthcare spending in Mexico in year 2022. 311.56 k Total number of physicians in Mexico in 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 17 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.5 Healthcare Services Market in Mexico Mexico Healthcare Services Market Forecast, 2022-2030 (in $Mn) 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Healthcare Services market in Mexico, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 18 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.6 Healthcare Scenario in Mexico Patient Engagement Solutions Treatment Process: The process of developing a cancer drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the cancer drug development process: Preclinical Research: Researchers identify potential drug candidates and test them in the lab Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating cancer Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market o o o o o FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need ▪ Fast Track A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Breakthrough Therapy ▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved based on a surrogate endpoint Accelerated Approval ▪ Priority Review A Priority Review designation means FDA’s goal is to take action on an application within 6 months ▪ Illustrative Illustrative 19 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.6 Healthcare Scenario in Mexico: Patient Journey Presentation Diagnosis Treatment Follow up Confirmatory Diagnosis Complete blood count (evaluate number & quality of RBCs, Hb & WBCs) Prevention and management of crisis: • For VOC and Splenic Sequestration: HU, Endari, Adakveo, Oxbryta • For infections: Antibiotics, Vaccines • Long term follow-up is required for patients with SCD • Annual assessment: CBC and reticulocyte count, iron status, liver and renal function tests, urinalysis, LDH, vitamin D level and neurocognitive assessment • ESOD (End Stage Organ Damage) evaluation starting from age 7 • Yearly Transcranial Doppler test to determine risk of stroke Initial Diagnosis Imaging (confirm bone related changes or respiratory problems) A suspected diagnosis is usually made, based on physical examination and detailed patient and family history Prenatal screening/ Neonatal screening Bacterial cultures of blood, sputum, urine, stool (detect any infection) Prevention and management of complications: Genetic testing (detect the type of SCD) • Stroke: Chronic transfusions, HU Stakeholders PCP, pediatrician, neonatologist, endocrinologist, cardiologist, hematologist, orthopedist, psychologist and psychiatrist PCP, paediatrician, neonatologist, haematologist and genetic counsellor PCP, pediatrician, medical geneticist, cardiologist, hematologist, endocrinologist, psychologist and psychiatrist PCP, pediatrician, medical geneticist, hematologist, gynecologist and pathologist Depending on the organ complications, the treatment involves different specialists at different times Illustrative Illustrative 20 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.7 Health Insurance Coverage: Mexico % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare Medicaid 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 21 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.8 Budget of Mexico Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 In Billions Of Dollars Public Insarance 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% As % Of GDP National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 22 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 23 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
1.9 Mergers and Acquisitions (continued) Latest Deals In Mexico Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 24 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Mexico Patient Engagement Solutions Market Analysis 2. Market Size and Forecasting
2.1 Market Size and Forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Mexico Patient Engagement Solutions Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Patient Engagement Solutions market in Mexico, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 Major Markets Patient (Mn) In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Mexico Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 % of Mexico Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Mexico Market Size (Bn $) 61 74 84 87 91 95 99 106 Illustrative Illustrative 26 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
2.2 Snapshot of Patient Engagement Solutions Market Segmentation By Therapeutic area By Component By Functionality Chronic diseases Hardware E- Prescribing Cardiovascular diseases Virtual consultation Software Diabetes Patient Scheduling Services Document management Obesity Women’s health Others In this section you will get an understanding of the segmentations which will cover the Mexico Patient Engagement Solutions Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 27 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
2.2.1 Market Segmentation: By Component In component segment Software is a significant component of the overall Patient Engagement Solutions market in Mexico ▪ Mexico Patient Engagement Solutions Market Share, By component (2022) It has the maximum market share in Mexico Patient Engagement Solutions Market with approximately xx% ▪ Services Hardware Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Software Illustrative Illustrative 28 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
2.2.2 Market Segmentation: By Therapeutic Area In therapeutic area segment chronic diseases and cardiovascular diseases are a significant component of the overall Patient Engagement Solutions market in Mexico. ▪ Mexico Patient Engagement Solutions Market Share, By Therapeutic area (2022) It has the maximum market share in Mexico Patient Engagement Solutions Market with approximately xx% ▪ Others Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Women's health Chronic diseases Obesity In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Diabetes Cardiovascular diseases Illustrative Illustrative 29 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
2.2.3 Market Segmentation: By Functionality In functionality segment virtual consultation and patient scheduling are a significant component of the overall Patient Engagement Solutions market in Mexico. ▪ Mexico Patient Engagement Solutions Market Share, By Functionality (2022) It has the maximum market share in Mexico Patient Engagement Solutions Market with approximately xx% ▪ Document management E- Prescribing Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Patient scheduling Virtual consultation Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 30 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Mexico Patient Engagement Solutions Market Analysis 3. Market Dynamics
3.1 Market growth drivers 3.1.1 Growing cancer cases with above 0.25 Mn new cancer cases in Mexico in 2022 Increase in incidence of cancer cases in Mexico with people suffering from various cancers requiring patient engagement solutions. Out of all the cancers breast cancer, lung cancer and prostate cancers are the most prevalent in Mexico ▪ Increase in cancer cases in Mexico This is driving the demand for Patient Engagement Solutions such as patient scheduling and virtual consultation for growth in the Patient Engagement Solutions market. ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 32 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
3.1 Market growth drivers (continued) 3.1.2 Development of digital health (e-health) technologies and increase in patient spending on these technologies in Mexico Increase in patient spending on digital health technology Different areas of digital health technologies are developing rapidly in Mexico like portable devices, mobile health apps, telemedicine, electronic health records etc. ▪ These technologies are in constant development and evolution in Mexico ▪ Increase in spending on these facilities by patients acts as a market growth driver. ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 33 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
3.1 Market growth drivers (continued) 3.1.3 Growing geriatric population in Mexico at high rate with over 25% population above 60 years by 2050 Geriatric population is growing in Mexico at a very high rate. According to data by United Nations in 2020 the population aged 60 years and older reached 14.5 million representing 11% of total population. ▪ Due to increase in geriatric population patient engagement solutions are also increasing in Mexico thus acting as a market growth driver. ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 34 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
3.2 Market restraints 3.2.1 Privacy and data security concerns 3.2.2 Low health literacy and digital literacy levels in Mexico 3.2.3 High development costs of patient engagement solutions and lack of skilled IT professionals in Mexico Mexico has limited domestic production capabilities for Patient engagement programmes involve exchange of sensitive health information and therefore concerns about data security and privacy arise. Ensuring robust privacy measures and complying with data protection are therefore necessary. Market structure of Patient Low health literacy and low digital literacy levels especially among geriatric population acts as a market growth restraint. In this type of situation there is reluctancy to use digital solutions. ▪ ▪ High developmental costs of patient engagement solutions especially on premise databases and lack of skilled IT professionals in Mexico. Language and cultural diversity in Mexico also acts as barrier to development of patient engagement programmes. 68 National languages are recognized in Mexico. ▪ ▪ ▪ ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 35 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Mexico Patient Engagement Solutions Market Analysis 4. Competitive Landscape
4.1 Major Market Share Revenue of Major Players in Mexico Patient Engagement Solutions Market ($ Mn) Other Some of the top companies in Mexico Patient Engagement Solutions Market based on revenue and market share include ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ XX Illustrative Illustrative 37 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2 Key Company Profile 1 Epic Systems Key Notes 2 AdvancedMD Here is the list of top 10 companies which will cover in the final report Each company will have slides for Overview o Key details o Offerings o Name of products o Recent activities/ Press Coverage o Distribution and Vendor Partners o Mergers, Acquisitions and Collaboration o Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 3 Allscripts Healthcare ▪ 4 Athenahealth o 5 Cerner corporation 6 EMMI Solutions 7 GetWellNetwork 8 ▪ Lincor Solutions limited 9 McKesson Corporation ▪ 10 Medecision Inc. Illustrative Illustrative 38 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2.1 EPIC SYSTEMS CORPORATION Solutions offered by Epic ▪ Epic Systems corporation develops patient engagement software to provide patients with tools to be healthier with MyChart which is a patient portal ▪ It has many centers in the country and operates through online mode as well ▪ It has global presence in many countries including Mexico Founded in: 1979 ➢ Epic Electronic health record system HQ: Wisconsin, United states ➢ Tool for Population health management Type: Private ➢ Epic MyChart Website: www.epic.com ➢ Epic Care Ambulatory Recent Activity / Press Coverage Epic service corporation joins health information sharing framework called Trusted Exchange Framework and the Common Agreement (TEFCA) Epic, Microsoft together bring GPT-4 to Electronic health records Epic system is leader in EHR hospital market share with 83 hospitals joining its network in 2022 Illustrative Illustrative 39 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2.1 EPIC SYSTEMS CORPORATION Partnerships Ecosystem Major Distribution Partners Major Vendor Partners 40 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2.1 EPIC SYSTEMS CORPORATION Latest Deals - Mergers and Acquisitions Amount / Shares Company Type Year Key Pointers Partnership Collaboration is aimed to develop and integrate generative AI into healthcare by combining the scale and power of Azure OpenAI Service with epic’s electronic health record software Innovation is focused to increase productivity, enhance patient care and improve financial integrity of health systems ▪ Expanding Strategic collaboration -- April 2023 ▪ Illustrative Illustrative 41 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2.1 EPIC SYSTEMS CORPORATION Revenues ($Bn), 2020-2030 EPIC systems corporation is a one of the leading Patient Engagement Solutions company in Mexico ▪ As of December 31, 2022, the company had a market share of Xx % in the Patient Engagement Solutions industry in Mexico 70.9 ▪ 70.3 63.3 GNC Mexico reported a total revenue of RM Xx billion for the financial year ended November 30, 2022, representing a 11% increase from the previous year ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2022 Company's net profit after tax for the same period was RM Xx Mn, a Xx increase from the previous year ▪ 1 2 3 4 Illustrative Illustrative 42 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Cancer Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 43 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 44 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 45 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 46 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Mexico Patient Engagement Solutions Market Analysis 5. Reimbursement Scenario
5.1 Reimbursement Regulation in Mexico Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Population The reimbursement scenario in Mexico nutritional supplement market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: Public Insurence: o Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions o Medicare covers many cancer treatments, including chemotherapy, radiation therapy, and some immunotherapies o However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization o Medicaid is a joint federal-state program that provides health insurance for people with low incomes o Medicaid coverage for cancer treatments can vary by state, and may be subject to limits on the amount and type of treatment covered Private Insurance: o Private insurance coverage for cancer treatments can also vary widely depending on the insurer and the specific policy o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage ▪ Other Public 1% Other Private 3% Uninsured 9% Medicare 17% Medicaid and CHIP 21% ▪ Employer-Sponsored 49% Health Insurance Coverage, 2022 Illustrative Illustrative 48 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
5.1 Reimbursement Regulation in Mexico (continued) Affordable Care Act: Affordable Care Act (ACA) includes provisions to help improve access to cancer treatments by requiring insurers to cover certain preventive services, including cancer screenings, without co-pays or deductibles It also includes protections for people with pre-existing conditions, such as cancer Reimbursement for New Treatments: Reimbursement for new cancer treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage This can create challenges for companies developing and marketing new treatments Value-Based Care: There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics ▪ o o ▪ o o ▪ o o In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative 49 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
5.1 Reimbursement Regulation in Mexico (continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure 46.0% xx 47.7% xx xx xx 51.0% 51.8% xx Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities Medicaid is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 50 A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential